Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): A 1-yr prospective study.
European Journal of Haematology.
Times cited: 185
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
Times cited: 343
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
New England Journal of Medicine.
Times cited: 2320